首页> 外文期刊>Journal of clinical sleep medicine: JCSM : official publication of the American Academy of Sleep Medicine >Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study
【24h】

Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study

机译:持续正压通气治疗可能会改善阻塞性睡眠呼吸暂停的视神经功能:电生理研究

获取原文
       

摘要

Study Objectives:Obstructive sleep apnea (OSA) is a sleep disorder frequently associated with optic nerve diseases. Moreover, untreated patients with severe OSA may show optic nerve dysfunction as documented by electrophysiological studies using visual evoked potentials (VEP). Because continuous positive airway pressure (CPAP) treatment has proved to restore the physiologic nocturnal breathing, thus preventing nocturnal hypoxemia and reducing inflammation, in this study we tested whether 1-year CPAP treatment may modify VEP responses in patients with severe OSA.Methods:VEP were recorded at baseline and after 1 year of CPAP treatment in 20 patients with severe OSA, divided in two groups on the basis of CPAP adherence, and compared to a healthy control group.Results:Patients with good adherence to CPAP therapy (CPAP+; n = 10) showed VEP P100 amplitude significantly higher than patients with poor adherence to CPAP therapy (CPAP; n = 10). Moreover, the CPAP+ group showed VEP responses similar to those in the control group (n = 26). Considering the mean difference of VEP responses between baseline and follow-up, the CPAP+ group showed a significant increase in VEP P100 amplitude and a significant decrease in VEP P100 latency compared to the CPAP group.Conclusions:This study documented that CPAP therapy significantly improves VEP in patients with OSA who are adherent to the treatment. We hypothesize that CPAP treatment, minimizing the metabolic, inflammatory and ischemic consequences of OSA, may normalize the altered VEP responses in patients with OSA by restoring and preserving optic nerve function.
机译:研究目的:阻塞性睡眠呼吸暂停(OSA)是一种经常与视神经疾病相关的睡眠障碍。此外,未经治疗的严重OSA患者可能会出现视神经功能障碍,这是通过使用视觉诱发电位(VEP)进行的电生理研究证实的。由于连续气道正压(CPAP)治疗已被证明可以恢复生理性夜间呼吸,从而预防夜间低氧血症并减少炎症,因此在本研究中,我们测试了CPAP治疗1年是否可以改变严重OSA患者的VEP反应。在基线和CPAP治疗1年后对20例严重OSA患者进行了记录,根据CPAP依从性分为两组,并与健康对照组进行比较。结果:对CPAP依从性良好的患者= 10)显示VEP P100幅度明显高于对CPAP治疗依从性差的患者(CPAP; n = 10)。此外,CPAP +组的VEP反应与对照组相似(n = 26)。考虑到基线和随访之间VEP反应的平均差异,与CPAP组相比,CPAP +组显示VEP P100振幅显着增加,而VEP P100潜伏期显着减少。结论:本研究证明CPAP治疗可显着改善VEP坚持治疗的OSA患者。我们假设CPAP治疗可以最大程度地减少OSA的代谢,炎性和缺血性后果,可以通过恢复和保留视神经功能来使OSA患者的VEP反应正常化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号